Key Highlights
•
A study of adult hospital patients across 22 African countries found that 1 in 8 were critically ill, with about half of those suffering from respiratory failure. Despite oxygen being a World Health Organization essential medicine for over 20 years, approximately half of these patients were not receiving oxygen therapy, highlighting a critical gap in care for life-threatening conditions in low-resource settings.
Source →
•
A European study of patients with lung disease linked to a specific type of antibody found that the usual interstitial pneumonia pattern was the most common and was associated with a greater annual decline in lung function. The study suggests that a drug called rituximab may help preserve lung function, underscoring the need for early identification and personalized treatment for these complex conditions.
Source →
•
A phase 3 trial showed that adding chemotherapy to the targeted drug aumolertinib significantly extended the time before cancer worsened in patients with a specific type of advanced lung cancer who also had mutations in tumor suppressor genes. This provides the first prospective evidence that intensifying treatment based on a patient’s genetic profile can improve outcomes for this molecularly defined group.
Source →
•
The first randomized trial on the timing of immunotherapy found that giving checkpoint inhibitors in the morning significantly extended survival for patients with advanced non-small cell lung cancer. This provides strong evidence that aligning cancer treatment with the body’s natural daily rhythms is a simple, non-invasive way to potentially improve patient outcomes.
Source →
•
A large study of over 2,200 patients with cardiac amyloidosis, a condition that can affect the heart and lungs, found that nearly 40% of patients did not have a preserved heart pumping function, challenging the common belief that this disease only causes one type of heart failure. Integrating different heart imaging measurements provided a better way to predict patient survival, arguing for a more comprehensive approach to diagnosis and management.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
